PL4185580T3 - Stałe postacie belumsudilu i soli belumsudilu - Google Patents
Stałe postacie belumsudilu i soli belumsudiluInfo
- Publication number
- PL4185580T3 PL4185580T3 PL21755332.0T PL21755332T PL4185580T3 PL 4185580 T3 PL4185580 T3 PL 4185580T3 PL 21755332 T PL21755332 T PL 21755332T PL 4185580 T3 PL4185580 T3 PL 4185580T3
- Authority
- PL
- Poland
- Prior art keywords
- belumsudil
- salts
- solid forms
- solid
- forms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/04—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063054918P | 2020-07-22 | 2020-07-22 | |
| US202063075368P | 2020-09-08 | 2020-09-08 | |
| US202063104329P | 2020-10-22 | 2020-10-22 | |
| US202163137212P | 2021-01-14 | 2021-01-14 | |
| PCT/US2021/070924 WO2022020850A1 (en) | 2020-07-22 | 2021-07-22 | Solid state forms of belumosudil and belumosudil salts |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4185580T3 true PL4185580T3 (pl) | 2025-04-14 |
Family
ID=77338971
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL21755332.0T PL4185580T3 (pl) | 2020-07-22 | 2021-07-22 | Stałe postacie belumsudilu i soli belumsudilu |
Country Status (14)
| Country | Link |
|---|---|
| US (5) | US11773083B2 (pl) |
| EP (2) | EP4480483A3 (pl) |
| JP (3) | JP2023535447A (pl) |
| KR (1) | KR20230043910A (pl) |
| CN (2) | CN119219610B (pl) |
| CA (1) | CA3186800A1 (pl) |
| ES (1) | ES3007246T3 (pl) |
| HR (1) | HRP20241789T1 (pl) |
| HU (1) | HUE069889T2 (pl) |
| IL (1) | IL300040A (pl) |
| PL (1) | PL4185580T3 (pl) |
| PT (1) | PT4185580T (pl) |
| SI (1) | SI4185580T1 (pl) |
| WO (1) | WO2022020850A1 (pl) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL300040A (en) | 2020-07-22 | 2023-03-01 | Teva Pharmaceuticals Int Gmbh | Crystalline forms of blomosodil and salts of blomosodil |
| WO2022170864A1 (zh) * | 2021-02-09 | 2022-08-18 | 苏州科睿思制药有限公司 | Belumosudil甲磺酸盐的晶型及其制备方法和用途 |
| CN115124514A (zh) * | 2021-03-26 | 2022-09-30 | 广东东阳光药业有限公司 | Kd-025的共晶及其制备方法 |
| US20240343712A1 (en) * | 2021-07-16 | 2024-10-17 | Sandoz Ag | Solid-state forms of 2-(3-(4-(1h-indazol-5-ylamino)quinazolin-2-yl)phenoxy)-n-isopropylacetamide methane sulfonic acid salt |
| WO2024000060A1 (en) * | 2022-06-30 | 2024-01-04 | Apotex Inc | Salts of belumosudil, crystalline forms and pharmaceutical compositions thereof and their use in the treatment of chronic graft-versus-host disease |
| WO2024063770A1 (en) * | 2022-09-21 | 2024-03-28 | Kadmon Corporation, Llc | Liquid formulation of belumosudil |
| IL320719A (en) | 2022-11-11 | 2025-07-01 | Assia Chem Ind Ltd | Solid forms of blomosodil and processes for obtaining blomosodil |
| CN117603194A (zh) * | 2023-10-30 | 2024-02-27 | 南京科默生物医药有限公司 | 一种甲磺酸贝舒地尔的晶型及其制备工艺 |
| WO2025257846A1 (en) * | 2024-06-14 | 2025-12-18 | Natco Pharma Limited | An improved process for the preparation of belumosudil mesylate and its intermediates thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CR9465A (es) * | 2005-03-25 | 2008-06-19 | Surface Logix Inc | Compuestos mejorados farmacocineticamente |
| CA2700988A1 (en) | 2006-09-27 | 2008-05-08 | Surface Logix, Inc. | Rho kinase inhibitors |
| WO2012040499A2 (en) | 2010-09-22 | 2012-03-29 | Surface Logix, Inc. | Metabolic inhibitors |
| EP2903618B1 (en) | 2012-10-05 | 2022-06-01 | Kadmon Corporation, LLC | Rho kinase inhibitors |
| WO2015157556A1 (en) | 2014-04-09 | 2015-10-15 | Kadmon Corporation, Llc | Treatment of gvhd |
| CN106916145B (zh) | 2017-03-06 | 2019-06-04 | 上海应用技术大学 | SLx-2119的合成方法 |
| CN114746412A (zh) | 2019-12-27 | 2022-07-12 | 广东东阳光药业有限公司 | Kd-025的新晶型及其制备方法 |
| EP3875078A1 (en) * | 2020-03-06 | 2021-09-08 | Dompe' Farmaceutici S.P.A. | Compounds for the treatment of covid-19 |
| IL300040A (en) | 2020-07-22 | 2023-03-01 | Teva Pharmaceuticals Int Gmbh | Crystalline forms of blomosodil and salts of blomosodil |
| WO2022170864A1 (zh) | 2021-02-09 | 2022-08-18 | 苏州科睿思制药有限公司 | Belumosudil甲磺酸盐的晶型及其制备方法和用途 |
| CN114907325A (zh) * | 2021-02-09 | 2022-08-16 | 苏州科睿思制药有限公司 | Belumosudil甲磺酸盐的晶型及其制备方法和用途 |
| CN115073430A (zh) * | 2021-03-10 | 2022-09-20 | 苏州科睿思制药有限公司 | Belumosudil甲磺酸盐的晶型及其制备方法和用途 |
-
2021
- 2021-07-22 IL IL300040A patent/IL300040A/en unknown
- 2021-07-22 JP JP2023504631A patent/JP2023535447A/ja active Pending
- 2021-07-22 ES ES21755332T patent/ES3007246T3/es active Active
- 2021-07-22 EP EP24204028.5A patent/EP4480483A3/en active Pending
- 2021-07-22 SI SI202130256T patent/SI4185580T1/sl unknown
- 2021-07-22 HR HRP20241789TT patent/HRP20241789T1/hr unknown
- 2021-07-22 EP EP21755332.0A patent/EP4185580B8/en active Active
- 2021-07-22 KR KR1020237005948A patent/KR20230043910A/ko active Pending
- 2021-07-22 PL PL21755332.0T patent/PL4185580T3/pl unknown
- 2021-07-22 CN CN202411335318.5A patent/CN119219610B/zh active Active
- 2021-07-22 CN CN202180053875.6A patent/CN116390918B/zh active Active
- 2021-07-22 WO PCT/US2021/070924 patent/WO2022020850A1/en not_active Ceased
- 2021-07-22 HU HUE21755332A patent/HUE069889T2/hu unknown
- 2021-07-22 CA CA3186800A patent/CA3186800A1/en active Pending
- 2021-07-22 PT PT217553320T patent/PT4185580T/pt unknown
-
2022
- 2022-12-06 US US18/075,513 patent/US11773083B2/en active Active
-
2023
- 2023-08-22 US US18/236,458 patent/US11932627B2/en active Active
- 2023-12-22 US US18/393,915 patent/US12157729B2/en active Active
-
2024
- 2024-11-08 US US18/941,174 patent/US20250066334A1/en active Pending
- 2024-11-08 US US18/941,154 patent/US20250066333A1/en active Pending
-
2025
- 2025-04-28 JP JP2025074604A patent/JP2025113269A/ja active Pending
- 2025-09-19 JP JP2025156398A patent/JP2026047356A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4480483A2 (en) | 2024-12-25 |
| US20250066333A1 (en) | 2025-02-27 |
| HUE069889T2 (hu) | 2025-04-28 |
| US11932627B2 (en) | 2024-03-19 |
| CN119219610A (zh) | 2024-12-31 |
| US20250066334A1 (en) | 2025-02-27 |
| US20240124425A1 (en) | 2024-04-18 |
| CN116390918A (zh) | 2023-07-04 |
| US20230391755A1 (en) | 2023-12-07 |
| EP4185580A1 (en) | 2023-05-31 |
| ES3007246T3 (en) | 2025-03-19 |
| JP2025113269A (ja) | 2025-08-01 |
| US20230117059A1 (en) | 2023-04-20 |
| EP4185580B1 (en) | 2024-11-13 |
| SI4185580T1 (sl) | 2025-05-30 |
| IL300040A (en) | 2023-03-01 |
| CN119219610B (zh) | 2026-03-06 |
| HRP20241789T1 (hr) | 2025-03-14 |
| WO2022020850A1 (en) | 2022-01-27 |
| EP4480483A3 (en) | 2025-02-26 |
| PT4185580T (pt) | 2025-01-16 |
| JP2023535447A (ja) | 2023-08-17 |
| KR20230043910A (ko) | 2023-03-31 |
| JP2026047356A (ja) | 2026-03-13 |
| CA3186800A1 (en) | 2022-01-27 |
| US12157729B2 (en) | 2024-12-03 |
| CN116390918B (zh) | 2024-12-24 |
| EP4185580B8 (en) | 2024-12-18 |
| US11773083B2 (en) | 2023-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20260152T1 (hr) | Čvrsti oblici trilacikliba i soli trilacikliba | |
| IL287940A (en) | Fgfr inhibitors and methods of use thereof | |
| IL318420A (en) | Kras inhibitors | |
| PL3788047T3 (pl) | Stałe postacie inhibitora fgfr i sposoby ich otrzymywania | |
| DK4146348T3 (da) | Inhibitorer af nek7-kinase | |
| EP4524135A4 (en) | KINESIN INHIBITOR KIF18A AND ITS USE | |
| IL283592A (en) | Inhibitors of apol1 and methods of using same | |
| IL287768A (en) | Kcnt1 inhibitors and methods of use | |
| IL287751A (en) | Kcnt1 inhibitors and methods of use | |
| HRP20251592T1 (hr) | Inhibitori arginaze i metode njihove primjene | |
| HUE069889T2 (hu) | Belumoszudil és belumoszudil-sók szilárd formái | |
| HRP20211779T4 (hr) | Postupak priprave derivata kinolin-2-il-fenilamina i njihovih soli | |
| EP4466269A4 (en) | PARP1 INHIBITORS AND THEIR USES | |
| IL312076A (en) | Methionine adenosyltransferase 2a (mat2a) inhibitors and uses thereof | |
| EP4240363A4 (en) | 2-AMINOQUINAZOLINE 7-PHENYL SUBSTITUTED, HPK1 INHIBITORS | |
| IL299700A (en) | Kcnt1 inhibitors and methods of use | |
| IL286485A (en) | Pi4-kinase inhibitors and methods of using the same | |
| IL299840A (en) | Inhibitors of complement factors and uses thereof | |
| IL292860A (en) | Allosteric egfr inhibitors and methods of use thereof | |
| EP4240361A4 (en) | INHIBITORS, OF THE 7-AZOLE SUBSTITUTED 2-AMINOQUINAZOLINE TYPE, OF HPK1 | |
| EP4244205A4 (en) | IRE1ALPHA INHIBITORS AND THEIR USES | |
| EP4408853A4 (en) | LPXC INHIBITORS AND THEIR USES | |
| DK4192813T3 (da) | Inhibitorer af transglutaminaser | |
| EP4384164A4 (en) | HYPOXIA-INDUCIBLE FACTOR INHIBITORS | |
| EP4316492A4 (en) | Combined use of multikinase inhibitor |